2014–2015 Influenza Activity and Antiviral Recommendations

Date:Wednesday, January 14, 2015

Presenter(s)

Overview

The latest FluView report indicates that flu activity remains high in the United States and is now widespread in 46 states and Guam. It has been recognized for many years that people 65 years and older are at higher risk of serious complications from the flu, and this flu season the hospitalization rates in this age group are climbing steeply. CDC recommends that all hospitalized and high risk patients (either hospitalized or outpatient) with suspected influenza should be treated as soon as possible with one of three available influenza antiviral medications, without waiting for confirmatory influenza testing. During this COCA Webinar, clinicians will learn about 2014-2015 influenza activity, hear a summary of CDC’s current antiviral recommendations, and gain insight into data that inform the antiviral recommendations.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

• Describe the current status of influenza activity in the United States.
• Discuss the timing of antiviral treatment and implications for patient evaluation, treatment and testing.
• State the latest antiviral recommendations for treating patients, especially older patients, with influenza.

Call Materials

• Slides:View Now
• Transcript:Read Now
• Audio:Listen Now
• Webcast:Watch Now

Additional Resources

• CDC Influenza Information for Health Professionals
• CDC Influenza Activity and Surveillance
• CDC Influenza Antiviral Medications: Summary for Clinicians
• CDC Influenza Prevention and Control of Seasonal Influenza with Vaccines
• Health Alert Network (HAN) - CDC Health Update Regarding Treatment of Patients with Influenza with Antiviral Medications. January 9, 2015
• Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season. Morbidity and Mortality Weekly Report (MMWR). August 15, 2014 / 63(32);691-697

• Prevention Strategies for Seasonal Influenza in Healthcare Settings

Call Format

• Audio conference call on 1/14/15: 1:00 - 2:00 PM
• Web-on-demand training after 3:00 PM on 1/14/15
• Materials: PowerPoint slide set

Accreditation Statements

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 1.0 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 0 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 1.0 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-15-072-L04-P and enduring 0387-0000-15-072-H04-P course category.

This program is knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.2 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.